UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 155 filers reported holding UNIQURE NV in Q1 2021. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,014 | -99.7% | 449,112 | +1485.8% | 0.01% | +400.0% |
Q2 2021 | $872,000 | -75.2% | 28,321 | -72.9% | 0.00% | -75.0% |
Q1 2021 | $3,517,000 | -56.1% | 104,400 | -53.0% | 0.00% | -55.6% |
Q4 2020 | $8,019,000 | +586.0% | 221,940 | +647.3% | 0.01% | +800.0% |
Q3 2019 | $1,169,000 | -91.4% | 29,700 | -82.9% | 0.00% | -91.7% |
Q2 2019 | $13,575,000 | +205.9% | 173,700 | +133.5% | 0.01% | +200.0% |
Q1 2019 | $4,438,000 | +50.7% | 74,400 | -75.7% | 0.00% | +33.3% |
Q3 2017 | $2,944,000 | +36.6% | 306,700 | -11.9% | 0.00% | 0.0% |
Q2 2017 | $2,155,000 | -0.3% | 348,100 | -6.9% | 0.00% | 0.0% |
Q1 2017 | $2,162,000 | +53.7% | 374,000 | +48.8% | 0.00% | +50.0% |
Q4 2016 | $1,407,000 | -21.8% | 251,300 | +6.8% | 0.00% | -33.3% |
Q3 2016 | $1,800,000 | +54.8% | 235,350 | +49.2% | 0.00% | +50.0% |
Q2 2016 | $1,163,000 | -52.4% | 157,790 | -23.3% | 0.00% | -60.0% |
Q1 2016 | $2,445,000 | +40.5% | 205,800 | +95.6% | 0.01% | +25.0% |
Q4 2015 | $1,740,000 | – | 105,200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 155,500 | $11,803,000 | 2.66% |
Aquilo Capital Management, LLC | 901,490 | $16,290,000 | 2.39% |
Nantahala Capital Management | 2,811,459 | $50,803,000 | 2.25% |
Privium Fund Management B.V. | 493,229 | $8,913,000 | 1.97% |
683 Capital Management, LLC | 1,355,000 | $24,485,000 | 1.31% |
Henry James International Management Inc. | 125,622 | $2,270,000 | 0.90% |
Integral Health Asset Management, LLC | 170,000 | $3,072,000 | 0.80% |
Nantahala Capital Management | 890,000 | $16,082,000 | 0.71% |
Sonic Fund II, L.P. | 50,000 | $904,000 | 0.51% |
Voss Capital, LLC | 70,000 | $1,265,000 | 0.40% |